Heartburn drug suspended from sale

Heartburn drug suspended from sale - US retailer CVS has become the latest to suspend the sale of a heartburn drug being investigated for links to cancer. The move comes after concern in several countries over the presence of impurities in Zantac and other ranitidine products. Canada and France have already announced Zantac recalls. The US and the European Union are investigating. Health authorities say there is no immediate risk, but patients have been advised to consult a doctor who can prescribe alternatives to ranitidine.

Last local news

Evening Update Tuesday 26 January 2021

Several mayors in the Alpes-Maritimes have issued a joint open letter saying that they note the fall in the number of doses for vaccination centers an... Evening Update Tuesday 26 January 2021 Read More

26/01/2021

Lunchtime News Tuesday 26th January 2021

Local MP Eric Ciotti has criticised what he calls the French government’s “procrastination” in the face of Covid health crisis. While speaking to Fren... Lunchtime News Tuesday 26th January 2021 Read More

26/01/2021

Travel due to Covid restrictions

Travel in France and abroad is subject to health restrictions due to the resurgence of the Covid-19 epidemic and the appearance of new variants of the... Travel due to Covid restrictions Read More

26/01/2021